Qiu Li-hua, Wang Hua-qing, Qian Zheng-zi, Li Wei, Hou Yun, Meng Xiang-rui, Cui Xiu-zhen, Hao Xi-shan
Department of Lymphoma, Tianjin Medical University Affiliated Cancer Hospital, Tianjin 300060, China.
Zhonghua Wai Ke Za Zhi. 2010 May 15;48(10):743-6.
To explore the morbidity, clinical characteristics, diagnosis, metastasis, treatment and prognosis of primary breast lymphoma (PBL).
From January 1960 to August 2007, 49 cases with PBL were treated among 22811 cases of breast malignancy and 7337 cases of malignant lymphoma. The clinical data of these 49 patients, included gender, age, pathologic type, breast X ray and B ultrasound examination results, involved lymph nodes and organs, treatment, survival time, were retrospectively analyzed.
From 1960 to 2007, the incidence rate of PBL in Tianjin Municipality was 59/10 millions; in details, the incidence rate of PBL for every 10 years was 2/10 millions, 3/10 millions, 0, 13/10 millions and 32/10 millions, respectively. According to circle graph of age, PBL occurred frequently in female aged 30 to 59 years. Most of this group of PBL was non-Hodgkin lymphoma (48 cases). No typical characteristics was found with the examination of breast X ray, B ultrasound and frozen section pathology. Bone marrow (9 cases), lung (7 cases), meninges (4 cases) and ovary (4 cases) were frequently involved organs. The overall 5-year survival rate was 6.1% for the group. The prognosis in patients with radical mastectomy combined chemotherapy was much better than that in patient received super to local mastectomy plus chemotherapy or simple tumor resection plus chemotherapy (5-year survival rates were 21.4%, 0, 0, respectively).
PBL is a kind of rare lymphoma with incidence increasing sharply in the past few decades. The clinical manifestation is atypical. Diagnosis of PBL should adopt histological examination. Radical mastectomy combined chemotherapy could bring better prognosis, but the prognosis is still poor.
探讨原发性乳腺淋巴瘤(PBL)的发病率、临床特征、诊断、转移、治疗及预后。
1960年1月至2007年8月,在22811例乳腺恶性肿瘤和7337例恶性淋巴瘤患者中,共治疗49例PBL患者。对这49例患者的临床资料,包括性别、年龄、病理类型、乳腺X线及B超检查结果、受累淋巴结及器官、治疗情况、生存时间等进行回顾性分析。
1960年至2007年,天津市PBL发病率为59/1000万;具体而言,每10年PBL发病率分别为2/1000万、3/1000万、0、13/1000万和32/1000万。根据年龄圆形图,PBL多见于30至59岁女性。该组PBL大多为非霍奇金淋巴瘤(48例)。乳腺X线、B超及冰冻切片病理检查均未发现典型特征。骨髓(9例)、肺(7例)、脑膜(4例)和卵巢(4例)是常见的受累器官。该组患者总体5年生存率为6.1%。根治性乳房切除术联合化疗患者的预后明显优于接受扩大局部乳房切除术加化疗或单纯肿瘤切除术加化疗的患者(5年生存率分别为21.4%、0、0)。
PBL是一种罕见的淋巴瘤,在过去几十年中发病率急剧上升。临床表现不典型。PBL的诊断应采用组织学检查。根治性乳房切除术联合化疗可带来较好的预后,但预后仍然较差。